KORIAN (KORI.PA)

FR0010386334 - Common Stock

7.36  -0.29 (-3.79%)

Fundamental Rating

2

KORI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Health Care Providers & Services industry. While KORI is still in line with the averages on profitability rating, there are concerns on its financial health. KORI is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

In the past year KORI was profitable.
In the past year KORI had a positive cash flow from operations.
KORI had positive earnings in each of the past 5 years.
In the past 5 years KORI always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 0.15%, KORI is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
The Return On Equity of KORI (0.62%) is worse than 76.19% of its industry peers.
KORI has a Return On Invested Capital of 2.43%. This is in the lower half of the industry: KORI underperforms 66.67% of its industry peers.
KORI had an Average Return On Invested Capital over the past 3 years of 2.49%. This is below the industry average of 5.63%.
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROIC 2.43%
ROA(3y)0.36%
ROA(5y)0.75%
ROE(3y)1.49%
ROE(5y)2.76%
ROIC(3y)2.49%
ROIC(5y)3.01%

1.3 Margins

KORI has a Profit Margin of 0.50%. This is in the lower half of the industry: KORI underperforms 76.19% of its industry peers.
KORI's Profit Margin has declined in the last couple of years.
KORI has a better Operating Margin (7.54%) than 76.19% of its industry peers.
KORI's Operating Margin has declined in the last couple of years.
The Gross Margin of KORI (92.07%) is better than 95.24% of its industry peers.
KORI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
OM growth 3Y-8.77%
OM growth 5Y-3.82%
PM growth 3Y-46.1%
PM growth 5Y-37.51%
GM growth 3Y-0.1%
GM growth 5Y0.03%

0

2. Health

2.1 Basic Checks

KORI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
KORI has more shares outstanding than it did 1 year ago.
KORI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KORI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that KORI is in the distress zone and has some risk of bankruptcy.
KORI has a worse Altman-Z score (0.51) than 76.19% of its industry peers.
KORI has a debt to FCF ratio of 34.46. This is a negative value and a sign of low solvency as KORI would need 34.46 years to pay back of all of its debts.
KORI has a worse Debt to FCF ratio (34.46) than 66.67% of its industry peers.
KORI has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
KORI's Debt to Equity ratio of 1.96 is on the low side compared to the rest of the industry. KORI is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF 34.46
Altman-Z 0.51
ROIC/WACC0.82
WACC2.97%

2.3 Liquidity

KORI has a Current Ratio of 0.63. This is a bad value and indicates that KORI is not financially healthy enough and could expect problems in meeting its short term obligations.
KORI's Current ratio of 0.63 is on the low side compared to the rest of the industry. KORI is outperformed by 71.43% of its industry peers.
A Quick Ratio of 0.62 indicates that KORI may have some problems paying its short term obligations.
KORI has a Quick ratio of 0.62. This is in the lower half of the industry: KORI underperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.62

3

3. Growth

3.1 Past

The earnings per share for KORI have decreased strongly by -77.10% in the last year.
KORI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.91% yearly.
The Revenue has been growing slightly by 7.27% in the past year.
KORI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.23% yearly.
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y-36.91%
EPS Q2Q%-85.96%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y7.23%
Sales Q2Q%6.66%

3.2 Future

KORI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.31% yearly.
Based on estimates for the next years, KORI will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y-69.88%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%
EPS Next 5YN/A
Revenue Next Year8.42%
Revenue Next 2Y7.06%
Revenue Next 3Y6.39%
Revenue Next 5Y5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.74, which means the current valuation is very expensive for KORI.
Based on the Price/Earnings ratio, KORI is valued a bit more expensive than 76.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.24, KORI is valued a bit more expensive.
KORI is valuated rather expensively with a Price/Forward Earnings ratio of 24.99.
Based on the Price/Forward Earnings ratio, KORI is valued a bit more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 19.93, KORI is valued a bit more expensive.
Industry RankSector Rank
PE 38.74
Fwd PE 24.99

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KORI is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
KORI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KORI is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.27
EV/EBITDA 8.71

4.3 Compensation for Growth

A cheap valuation may be justified as KORI's earnings are expected to decrease with -17.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

4

5. Dividend

5.1 Amount

KORI has a Yearly Dividend Yield of 3.27%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.07, KORI pays a better dividend. On top of this KORI pays more dividend than 80.95% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, KORI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

On average, the dividend of KORI grows each year by 10.51%, which is quite nice.
Dividend Growth(5Y)10.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

262.13% of the earnings are spent on dividend by KORI. This is not a sustainable payout ratio.
The Dividend Rate of KORI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP262.13%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

KORIAN

EPA:KORI (6/19/2023, 7:00:00 PM)

7.36

-0.29 (-3.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap783.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 38.74
Fwd PE 24.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.63
Quick Ratio 0.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y
EPS Q2Q%
EPS Next Y-69.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y